Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-46
Closed -$6K – 782
2022
Q1
$6K Buy
+46
New +$6.12K ﹤0.01% 782
2021
Q4
– Sell
-37
Closed -$6K – 802
2021
Q3
$6K Buy
37
+6
+19% +$934 ﹤0.01% 852
2021
Q2
$5K Sell
31
-1
-3% -$147 ﹤0.01% 856
2021
Q1
$4K Sell
32
-11
-26% -$1.6K ﹤0.01% 776
2020
Q4
$6K Buy
43
+4
+10% +$444 ﹤0.01% 789
2020
Q3
$4K Buy
39
+9
+30% +$755 ﹤0.01% 785
2020
Q2
$2K Buy
30
+6
+25% +$413 ﹤0.01% 785
2020
Q1
$1K Buy
+24
New +$1.88K ﹤0.01% 781

Other funds holding APTV

Candriam SCA's APTV Position: Q2 2022 in Review

Candriam SCA sold out of Aptiv (APTV) in Q2 2022, closing a stake of 46 shares — an estimated $6K sold.

Candriam SCA first reported a position in APTV in Q1 2020 and held it in 8 quarters. The position peaked at $6K in Q1 2022. 744 funds tracked by Wall St. Rank hold APTV as of Q2 2022.

  • Candriam SCA reported no remaining Aptiv position as of Q2 2022 after selling out during the quarter.
  • Candriam SCA sold 46 Aptiv shares in Q2 2022, an estimated $6K.
  • Candriam SCA first reported a position in Aptiv in Q1 2020 and held it in 8 quarters.
  • Candriam SCA's Aptiv position peaked at $6K in Q1 2022.
  • 744 funds tracked by Wall St. Rank held Aptiv as of Q2 2022.

Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.